The overall impact of AMPK activation on lipolysis remains controversial, and future studies are needed to elucidate the effects of chronic AMPK activation on tissue specificity and systemic lipid metabolism, which may have crucial implications for the treatment of obesity. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.